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ABSTRACT 
In the present study, propylene glycol monostearate 
(PGM), ethoxylated stearyl alcohol (ESA) .and combination 
thereof have been investigated for their film-forming paten-
f------lt-i-a-l-.--'I'-he-vle-t-t----ab-i-1-i-t-y----,---------st-r-e-n-g-t-h-, -a-n-d-i-n-t-e-gr i----t---'y -o-f--- t-h-e--fi-1-m~-c-----
were evaluated by measuing the contact angles and modulus 
of elasticity. The films of mixed composition had smaller 
contact angle than the films of either component. The 
modulus of elasticity of all films tested was in the range 
2 of 0.19 - 0.40 Kg/em . A series of experiments were con-
ducted in vitro to study the effect of changes in film com-
position, drug concentration and rate of agitation on 
cortisol release. Films of varying compositions contain-
ing 10 to 20% wjw ESA with corresponding decrease in PGM con-
centration with 4% wjw cortisol were found to release from 
15 to 90% of cortisol during 12 hour period. Unidirectional 
drug release from all film matrices was found to follow 
first-order kinetic profile over first five hours of drug 
.l.. 
release. The examination of Q versus t 2 plots (granular 
matrix) revealed linearity for first five hours of drug 
release but curvilinear effect beyond. First-order release 
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The application of a drug dispersed in an inert mat-
trix to achieve controlled relase has drawn great attention 
from researchers for the past two decades. This concept 
has been demonstrated to offer several advantages over con-
ventional dosage forms. Less frequent dosing with prolonged 
action formulations, compared to the regular-release equiva-
lent, is an important advantage. Patient acceptability was 
found to be another important consideration. Furthermore, 
a prolonged action mechanism may produce a more constant blood 
level of drug over a desired period of tiine resulting in 
fewer side effects. Also, the predictable control over 
rate and extent of absorption, and a possible decrease in 
the total dose of the drug are important benefits generally 
unavailable from the regular-release dosage forms. More 
recently, this method has been suggested for achieving con-
trolled release of drugs in ophthalmic (1) and dermatologic 
practice (2,3), buccal absorption (4), and formulation of 
long-acting implants (5,6). 
In the field of topical drug delivery systems, great 
interest has developed regarding the use of medicated polymeric 
films. Films of this type can be utilized as creams, solu-
tions, aerosols, or lotions to achieve percutaneous absorption 
1 
2 
of a therapeutically active substance. A variety of poly-
meric film-forming delivery systems have been investigated 
to achieve controlled drug release over a desired period of 
time (6,7), and for attaining other pharmaceutical objec-
tives such as improving topical drug penetration by increas-
ing hydration of skin by occlusion ( 8), and imparting wash 
and wear resistance to the site of application. 
----------------~r~tre--c~~e of percutaneous absorp~ion where sk1''n.--------------
serves as a natural barrier, the therapeutically active 
substance must reach the skin surface at an adequate rate 
from the vehicle to ensure optimal penetration. In other 
words, if the vehicle is a thin film, it is a prerequisite 
for the drug to be released from the film in order to attain 
~ 
~ the therapeutic objectives. Sciarra and Gidwani (3) pointed 
" i 
I out that the nature of the film had significant effect on 
l 
I 
the release of drug suggesting that film properties must be 
taken into consideration. The film former should be inert 
and incapable of complexation with the drug. The film 
should remain intact and continuous at the site of applica-
tion. The film surface in contact with the skin should 
have balanced hydrophilic-lipophilic characteristics to en-
sure uniform contact with the skin secretions, namely sweat 
and sebum. Continuous and uniform wetting of the film sur-
face by the skin secretions would ensure more predictable 
and constant drug release. The moisture vapor transmission 
characteristics of film-forming systems might also deserve 
consideration in view of the importance of hydration of 
--------------
3 
stratum corneum in improving topical absorption of drugs. 
Several polymeric substances have been studied for 
their film-forming characteristics and potential application 
in topical dosage forms (2,5,9). However, nonpolymeric sub-
stances do not appear to have been fully explored. Lanolin 
alcohol has been recently shown to form isolatable films on 
mercury substrate (10, 11). The release kinetics and in 
vitro skin penetration of triamcinolone acetonide from lano-
lin alcohol-ethyl cellulose films were also investigated 
in these studies. The potential application of such film 
compositions was further confirmed by Khan (12). Effective 
utilization of potential nonpolymeric film formers holds 
several promising features. The toxicologic hazards associ-
ated with monomeric impurities present in high molecular 
weight polymers could be minimized. Nonpolymeric materials 
are easy to manipulate and compound. They can be washed 
off from the skin by soap and water. Moreover, nonpoly-
meric substances can be obtained with relative ease in a 
state of more definable composition. 
In the present study, propylene glycol monostearate 
and ethoxylated stearyl alcohol have been investigated for 
their film-forming characteristics. A preliminary evalua-
tion of these potential film formers was conducted by measur-
ing the solubilities in water, isopropyl alcohol, and ethyl 
alcohol. The film-forming ability and integrity of the films 
have been demonstrated by casting the films on mercury substrate 
·~---·---···---- ·-·· ·-·· 
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and isolating the films therefrom. The wettability charac-
teristics of the film surface were evaluated by measuring 
the contact angles against water. The strength and elastic 
properties of the thin films were determined by measuring the 
hardness and modulus of elasticity at a given film thick-
ness. 
This work also describes the kinetics of drug re-
lease from selected compositions of thin films with varying 
proportions of propylene glycol monostearate and ethoxylated 
stearyl alcohol. For the purpose of these studies, cortisol 
was chosen as the model drug in view of its wide accept-
ability as an anti-inflammatory agent in topical dosage forms 
and demonstrated potential application in sustained release 
preparations (13,14). 
THEORY 
In the present study a film-forming delivery system 
composed of propylene glycol monostearate and ethoxylated 




solubility of cortisol in propylene glycol monostearate or 
ethoxylated stearyl alcohol is assumed as negligible. 
Theoretical treatments of the mechanism of drug 
release from inert film matrices containing dispersed drug 
in solid phase assume that the rate controlling step is in 
the applied film, therefore, the skin properties can be 
ignored. Concentration gradient, if any, is assumed to 
occur in the vehicle and the skin can be regarded as a per-
feet sink. Because of the great resistance of the intact 
skin only a negligible concentration gradient may develop 
in the applied film in the direction normal to the skin sur-
face. The concentration of the penetrat.ing substance in the 
skin is essentially zero because of rapid dissipation into 
deeper tissues. For these systems, drug concentration in the 
vehicle, diffusion coefficient of th~ drug molecule in the 
vehicle, and solubility of the drug in the same are the 
important factors. 
Based upon the assumptions mentioned above, Higuchi 
(5) has derived quantitative relationships governing such 
5 
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situations. Two mechanisms of drug release from such delivery 
systems having unidirectional leaching or extraction from a 
simple planar surface have been proposed (16). 
(i) release from a planar system having drug 
dispersed in a homogeneous matrix. 
(ii) release from a planar system having durg 
dispersed in a granular matrix. 
Drug Release from a Planar System Having a Homogeneous Matrix: 
The extraction of the drug is a simple diffusional 
process through and from an enveloping, homogeneous matr~x. 
The drug is presumed to go successively from the crystal 
surfaces into the uniform matrix and out into the bathing 
solvent which in turn acts as a perfect sink. The amount of 
total drug released from such a system could be determined 
by the relationship 
where: 
Q = A/ Dt(2A-C )C s s (Eq. 1) 
Q = the amount of drug released after time t per 
unit exposed area, 
D = the diffusivity of the drug in the homogeneous 
matrix media, 
A = the total amount of drug present in the matrix 
per unit volume, and 
Cs = the solubility of the drug in the matrix sub-
stance. 
7 
Drug Release from a Planar System Having a Granular Matrix: 
The drug is leached by the bathing fluid which is 
able to enter the matrix phase through pores, cracks, and inter-
granular spaces. The drug is presumed to dissolve slowly 
into the permeating fluid phase and to diffuse from the 
system along the cracks and capillary channels filled with 
the extracting solvent. Intragranular diffusion is assumed 
to be negligible. Equation 1 was modified for this type of 
release where diffusion can occur. 
where: 
Q =~DE (2A-£C )C t 
T s s (Eq. 2) 
Q = the amount of drug released after time t per 
unit exposed area, 
D = the diffusivity of the drug in the permeating 
fluid, 
T = the tortuosity factor of the capillary system, 
A = the total amount of drug present in the matrix 
per unit volume, 
C = the solubility of the drug in the permeating s 
fluid, and 
£ = the porosity of the matrix. 
The apparent solubility of the drug in the total sys-
tern per unit volume is decreased by the porosity factor. 
The tortuosity factor is introduced to correct for the length-
erred diffusional path caused by the necessary lateral excur-
sions. 
8 
Both equations are based on the existence of pseudo 
steady state condition during the release process and on the 
assumption that the drug particles are quite small relative 
to the average distance of diffusion and are uniformly dis-
tributed in the matrix. The equations would be essentially 
vai'i'd for systems in which A is greater than Cs or e:Cs by 
a factor of three or four. 
Although the two equations are for different mechanisms, 
they both describe drug release as being linear with the 
square root of time: 
J. 
Q = Kt 2 (Eq. 3) 
where K is the release rate constant. For a homogeneous 
matrix system: 
(Eq. 4) 
For a granular matrix system: 
KG= £e:(2A-e:C )C "-/-T s s ( Eq. 5) 
These relationships have been confirmed experimentally 
by a number of workers using plastic and wax matrixes (9, 17-
21). 
A first order release mechanism based 9n the Whitney-
Noyes equation is also considered as possible for this type 
of drug delivery systems. Sciarra and Gidwani (2) explained 
that the release of gentian violet from various plastic matrixes 





The first order release mechanism in which the release rate 
is proportional to the amount of drug left in the matrix can 
be shown as: 
where: 
-kt 
2.303 + (Eq. 6) 
Q
0 
= the initial amount of drug present per unit 
area of the film, 
Q = the amount of drug released per unit area at 
time t, and 
k = the first order rate constant. 
In this study the data for the release of cortisol 
from different film compositions were analyzed to determine 
which mechanism might be operative. 
Recently a new model for drug release from thin 
films has been proposed. The model treats the drug-containing 
film matrix and the skin as a bilayer membrane system. The 
drug is assumed to diffuse through each layer by a time-
dependent non-steady state process. This model has been succes·s-
fully·. applied to .the release of triamcinolone acetonide from 
a film containing lanolin alcohol, ethyl cellulose, and 







1. Propylene Glycol Monostearate (PGM), NF 
(Ruger Chemical Co. Inc., Irvington, NY) 
2. Ethoxylated Stearyl Alcohol (ESA), (Volpo 
R 
S.20 , Croda Inc., New York, NY, Ethoxyl 
content of 20 moles). 
Model Drug: 
1. Cortisol (CO), USP (Lot #0712833, Amend Drug 
& Chemical Co. Inc., Irvington, NJ) 
Solvent: 
1. Ethyl Alcohol, USP (Commercial Solvents Co., 
Agnew, CA) 
2. Isopropyl Alcohol, NF (Mallinckrodt, Inc., 
St. Louis, MO) 
Solubility Studies 
The solubilities of the film forming materials were 
determined in water, isopropyl alcohol, and ethyl alcohol 
at room temperature (22° _:1: 0.5°C). About 6 to 7 g of the 
film former was added to 20 ml of each solvent in 50-ml 
flasks with screw caps. A teflon-coated magnetic bar was 
placed in each flask prior to capping it tightly. The flasks 







motor and constant temperature was maintained throughout the 
stirring process for 48 hours. 
The stirring was stopped prior to sampling and the 
undissolved portion was allowed to settle. An aliquot was 
filtered using a glass funnel with filter paper. Two milli-
liters of filtrate were pipetted in a preweighed petri dish 
and dried in a drying oven at 50° for one hour. The petri 
dish was then left in a desicator for 24 hours at room tern-
perature and weighed again. The solubility was calculated 
from the weight change of the petri dish. All studies were 
conducted in duplicate. 
Preparation of Films for Initial Screening 
For preliminary screening, all films were prepared 
from a 5% (wjv) solution (or suspension in the case of 
propylene glycol monostearate). The required amount of a 
film forming agent was added to ethyl alcohol contained in 
a volumetric flask equipped with a magnetic stirring bar and 
contents were stirred for 24 hours with the flask tightly 
capped. 
The films were cast using the mercury substrate tech-
nique. Three milliliters of solution or suspension was poured 
1 on the surface of mercury contained in a 50x10 mm glass petri 
dish, which was then partially covered with its lid. This 
helps to control the solvent evaporation rate and reduce the 
blistering of the surface of the deposited film. 
150 mm in diameter and 10 mm in depth. 
----··----
12 
The solvent was allowed to evaporate overnight. The 
film formation can easily be noted by observing the mercury 
substrate after complete solvent evaporation. The film prep-
aration was carried out in a humidity controlled room at 25° 
and 40% relative humidity. Preliminary trials were carried 
out to establish time for complete evaporation. 
The resulting films were carefully removed from the 
mercury substrate and were individually stored between sheets 
of weighing paper inside a desicator over anhydrous calcium 
chloride 
Minimum isolatable film thicknesses were determined 
by measuring the intact film thicknesses isolated from 
mercury substrate cast with reducing amounts (2.5 ml, 2 ml, 
1.5 ml, and l ml) of solution or suspension. 
Contact Angle Measurements 
Films for contact angle measurements were cast on 
glass slides. A 25x75 mm slide was placed in a l00xl5 mm 
glass petri dish. Mercury was poured onto the dish suf-
ficient enough to surround the slide and to ensure that mer-
cury surface was higher than the surface of the slide. The 
solution (or suspension) of a film former was poured on 
the slide. The surrounding mercury made it possible to hold 
the film solution on the glass slide. The solvent was allowed 
to evaporate for 24 hours in a humidity controlled room 
as described above to ensure good film formation. 
The slide was lifted after complete evaporation of 
the solvent and was ready for contact angle measurements. The 
13 
film-coated slide was placed on an adjustable platform kept 
perfectly horizontal by means of a leveling device. A water 
drop of 1 ~1 was applied on the film using a microburette and 
was allowed to stand for 60 seconds to reach equilibrium 
before reading the contact angle. Contact angle was measured 
using a Reflective Goniometer2 fitted with a protractor 
scale and an objective lens (magnification x3). The entire 
unit was mounted on an adjustable stand. The hairline of 
the protractor eyepiece was adjusted to coincide with the 
surface of the film, and the intersection of the two hair-
lines was fixed at the film-water-air triple interface. The 
verticle hairline was then adjusted to make a tangent to the 
liquid-air interface. With this baseline adjustment completed 
in sixty seconds, the contact angle was read directly from the 
scale. 
Solid surfacesare nonhomogeneous and their surface 
energies are not evenly distributed. Therefore, the measure-
ment of contact angles was taken at five points on each test 
film. The mean value based upon five drops was calculated 
in this study. Contact angle here is in reality only an 
apparent value, however, it should be emphasized that these 
measurements are valid and provide a useful method of compar-
ing the wetting abilities of the different films studied. 
Determination of Hardness and Modulus of Elasticity 
For the determination of hardness and modulus of 
2 Kernco Instruments Co. Inc., El Paso, Texas. 
14 
elasticity, the solutions (or suspensions) of the film formers 
were prepared exactly as before. The film hardness was de~ 
termined on film cast on a polished aluminum plate (20x20 
em) using a Multiple Clearance Applicator3 producing a wet 
film thickness of about 1 mm. The Multiple Clearance Applica-
tor has a dimension of 10.2xl0.2xl em. It permits eight dif-
ferent thicknesses for the formation of films ranging from 
~--------5' to 50-ur1ls, a mil~nickness belng equlvalent to 25 ~m. 
The plate was dried in a humidity controlled room 
at 25° and 40% relative humidity. The dry film thickness 
was determined using a Minitector thickness measuring gauge 
(Model-N) 4 . It is necessary to ~ro the instrument on the 
same aluminum plate before each reading. The instrument was 
regularly calibrated using the standard foils provided with 
the instrument. 
Film hardness was determined using an automatic Sward 
Hardness Rocker. 4 This instrument has been used for measur-
ing the hardness of paint films (23) and to determine the 
Sward Hardness of some polymeric films (2) intended for pharma-
ceutical applications. 
The automatic rocker is fitted with a shutter that 
crosses a focused beam of light which provides automatic 
counting. The number of rocks is the result of the total 
number of oscillations given by the automatic counter mul-
tiplied by two. Before each measurement, the rocker was 
3Gardner Laboratory, Inc., Bethesda, Maryland. 
4 Gardner Laboratory, Inc., Bethesda, Maryland. 
----~ ~~~-"-----
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calibrated to show 100 rocks in 60 seconds on the standard 
polished glass plate. The glass plate was then replaced by 
the film-coated aluminum plate and the rocker was set in 
l motion. The number of rocks was measured by the average of three determinations rounded off to the nearest whole number. 
~ 
[I 
All measurements were made at room temperature. 
Modulus of elasticity E was calculated from the Sward 
Hardness R (number of rocks of the rocker on the test film): 
(Eq. 7) 
The values of constant K, for different thicknesses T, were 
obtained by plotting the different T values against standard 
K values on a semi-logarithmic paper. The standard values 
of K for different thicknesses are shown below (23): 
Thickness K 
0.0012" 1. 73 X 10-
9 
0.0024" 2.1 X 10-
8 
0.004" 1.3 X 10-
7 
0.125" 2.5 X 10-
2 
The precision of Sward Hardness reading is affected 
by large variations in temperature and the roughness of the 
film surface (23). 
Determination of Drug Release Kinetics 
The films were cast from a freshly prepared suspen-
sian containing 6.6% wjv solids (drug plus film formers), 
16 
using ethyl alcohol as the solvent. Ethoxylated stearyl 
alcohol and cortisol were added in required quantities to 
ethyl alcohol and were allowed to dissolve completely by 
stirring for a sufficient amount of time (approx. one hour). 
Propylene glycol monostearate was then added and stirring 
continued for another 24 hours to obtain a uniform dis-
persian. The stirring was stopped before samples were drawn. 
hree milliliters of this suspension was pipettedu into a 
preweighed, glass petri dish and was allowed to spread evenly 
across the bottom (60 mm in diameter) by gentle shaking. 
The petri dish was partially covered and kept on a 
level surface for at least 24 hours to ensure slow and uni-
form evaporation of solven.t. Complete evaporation was con-
firmed by weighing the petri dish to a constant weight. The 
film-coated petri dish was stored in a desiccator for at 
least 24 hours prior to the release study. Various film 
compositions prepared and investigated during the course of 
this study are listed in Table I. 
Following the procedures previously developed in 
this laboratory (10), the release studies were conducted 
in a dissolution assembly (Figures 1 and 2) with dissolution 
flasks replaced by 1000 ml flat bottomed glass beakers, and 
the dissolution basket assemblies replaced by stainless steel 
stirrers with a propeller of 45 mm diameter. Three hundred 
ml of distilled water were added carefully to each beaker 
5Pipetman R , Model p-5000D, Woburn, MA. 
---------~-----
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Table I. Compositions of the Films Studieda 
Propylene Ethoxylated 
Glycol Stearyl 
Film Monostearate Alcohol Cortisol 
No. (PGM) (ESA) (CO) 
1 0 96 4 
2 96 0 4 
3 94 2 4 
4 92 4 4 
5 90 6 4 
6 88 8 4 
7 86 10 4 
8 85 11 4 
9 84 12 4 
10 83 13 4 
11 82 14 4 
12 81 15 4 
13 80 16 4 
14 79 17 4 
15 78 18 4 
16 77 19 4 
17 76 20 4 
18 82.85 14.15 3 
19 83.71 14.29 2 
20 84.56 14.44 1 
-------
18 
Table I. (continued) 
Propylene Ethxylated 
Glycol Stearyl 
Film Monostearate Alcohol Cortisol 
No. (PGM) (ESA) (CO) 
21 81.84 15.16 3 
22 82.69 15.31 2 
23 83.53 15.47 1 
aPercent wfw based upon weight of the drug films. 
Propell€~r- Type Stirrer 
Plexiglass Cover F', ".J.<,::S...J 
'"' ~ :' : ' 
Glass Beoker-1--",.--~--...;--; 1 ·: --.,; _______ __ _ I 
, ' I ---...--
Dissolution 
Drive Control 
Gloss Petri Dish 'I;:-:: ;-r300 ml water --
1 ~!~',, 
Thin 
.,.,. - -l-~voter Both 25°C 
















Figure 2. Enlarged view of experimental beaker 
------~-------·-- -
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with a film-coated petri dish on the bottom. The distilled 
water was previously equilibrated at 25°. The stirring was 
maintained at 30 rpm and the water bath at 25° + 0.5°. 
Three ml samples were drawn6 at appropriate time 
intervals over a 12 hour period. Each sample was pipetted 
into a glass test tube and analyzed spectrophotometrically 
at 242 7 nm. 
The volume of each sample removed (3 ml) from the 
release cell was replaced by an equal volume of water pre-
viously equilibrated at 25°. A cumulative correction was 
made to determine the total amount released according to 
the following formula (24): 
where 
n-1 
X I c s (Eq. 8) s=l 
em = the spectrophotometrically measured concen-
tration, 
C = the concentration of the nth sampling expected 
--~ 
in the medium if previous samples had not been 
removed, 
n-1 = the total volume of all samples removed prior 
to the sample being measured, and 
C = the total of all spectrophotometrically measured 
s 
concentrations at n-1 samples. 
6Pipetman R , Model p-5000D, Woburn, MA. 
7 Bausch and Lamb, Spectronic 710. 
----~ -----~~~-- -
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The unidirectional release of the drug was assured 
by good adhesion of the film to the petri dish. No evidence 
of peeling or breaking of the films was observed during and 
at the termination of the experiments. The release data 
were calculated with the aid of a standard curve (Figure 3). 
All release studies were conducted in duplicate at room 
temperature. 
The effect of agitation rate on the drug release was 
studied using Film No. 12 (Table I) at 25°. Drug release 
was investigated at the stirring rates of 10, 30, 50, and 
80 revolutions per minute. 
To estimate the degree of reproducibility of sample 
withdrawals from suspension prior to filming casting, a sim-
ple method was developed. 
The selected composition was 82% wfw propylene glycol 
monostearate, 15% wfw ethoxylated stearyl alcohol, and 3% 
wfw cortisol. Five films were prpeared in the glass petri 
dish exactly in the same manner as the films for release 
study. Each film was placed in a beaker containing 300 ml 
distilled water and was stirred vigorously at 60° for 24 
hours to assure complete dissolution of cortisol. 
Films without cortisol, but containing the same 
amount of propylene glycol monostearate and ethoxylated stearyl 
alcohol were used as control in this experiment. 
The solution was filtered with a 0.22 ~m filter 
paper. 8 The first 5 ml of filtrate was rejected due to the 







5 10 15 
Concentration 10-3 mg/ml 
Figure 3. Standard curve for Cortisol 
20 
24 
adsorption of the steroid to the filter paper (25). The con-
centration of cortisol in the solvent was determined using 
a spectrophotometer and the Beer's law plot prepared in this 
concentration range. The data is presented in Table II. 
~~~~~~---~~-''"''""'"'"' ___ _ 
Table II. Degree of Variation Between the Film Weight and its !Cortisol Content 
Filma Expected Cojtisolb 
Variationc 
Actual Cortisol Between 
Trial Weight Content in Film Content in Flilm Actual and 
No. mg Absorbance mg mg Expected 
1 207.6 0.943 6.15 6.23 I 1. 3% 
2 196.9 0.913 5.94 5.91 0.5% 
3 196.3 0.908 5.91 5.89 0.3% 
4 201.4 0.928 6.06 6.04 0.3% 
5 203.2 0.929 6.06 6.10 0.7% 
aFilm composition of 82% wfw propylene glycol 
stearyl alcohol, and 3% wfw cortisol. 
monostearate, l5J w fw ethoxyla ted 
bExpected cortisol content was calculated from the weight of fillm. 
cMean, 0.62 + 0.41% 
"" CJl 
~------- ~~~~~-
RESULTS AND DISCUSSION 
The solubilities of film-forming agents were deter-
mined in water, isopropyl alcohol, and ethyl alcohol at 
22° + 0.5°C. Table III shows that the solubility of ethoxy-
lated stearyl alcohol was greater than 15% in all three 
solvents. Propylene glycol monostearate was found to form 
a uniform and stable suspension in all three solvents. Since 
propylene glycol monostearate is a mixture of the propylene 
glycol mono- and diesters of stearic and palmitic acids, 
the solubility of propylene glycol monostearate is reported 
in Table III simply as a reference. 
Film Preparation 
Attempts to prepare isolatable thin films of propylene 
glycol monostearate from clear solutions were unsuccessful. 
All propylene glycol monostearate films, including those of 
mixed composition with ethoxylated stearyl alcohol, were cast 
from suspension. Ethoxylated stearyl alcohol films could be 
cast readily from its solution in ethyl alcohol. 
The consistency of withdrawals and uniformity of 
suspensions prior to film preparation was checked. The data 
in Table II show a mean variation of 0.62% between actual 
and expected cortisol content during five trials. 
26 
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Both propylene glycol monostearate and ethoxylated 
stearyl alcohol were found to form thin films isolatable 
from the mercury substrate individually and together as 
mixed compositions. All films, regardless of composition, 
were translucent and flexible with smooth but slightly 
tacky surfaces. Film characteristics of selected film com-
positions are described in Table IV. 
a) Contact Angle: 
The contact angles of propylene glycol monostearate-
ethoxylated stearyl alcohol films were found to be smaller 
than those of either propylene glycol monostearate films or 
ethoxylated stearyl alcohol films. This may be due to in-
creased wettability and hydrophilicity of the film surface 
and lowered film-water interfacial tension caused by incor-
portion of ethoxylated stearyl alcohol. The significant de-
crease in contact angle suggested a uniform distribution of 
ethoxylated stearyl alcohol molecules in the matrix of pro-
pylene glycol monostearate molecules with polar groups of 
either in close proximity at the film surface. Thus, incor-
poration of ethoxylated stearyl alcohol into propylene glycol 
monostearate films would be expected to favor the release 
of cortisol from such film compositions baring any drug-
surfactant interaction especially in view of very high 
aqueous solubility of ethoxylated stearyl alcohol. The 
29 
Table IV. Physical Properties of Selected Propylene 




100 : 0 
Contactb 
Angle 














58.3 + 1.5 59.8 + 2. 7 
20.0 + l. 6 28.2 + 2.4 
19.8 + 1.8 28.0 + 2.2 













aExpressed as propylene glycol monostearate : ethoxylated 
stearyl alcohol ratio, % wjw. 
bExpressed as mean + standard deviation of 5 readings. 
cExpressed as mean + standard deviation of 5 measurements. 
30 
increase in the content of ethoxylated stearyl alcohol from 
10% to 20% wjw did not alter the contact angle of the film 
significantly. 
b) Insolatable Film Thickness: 
The minimum isolatable film thickness of propylene 
glycol monostearate-ethoxylated stearyl alcohol films was 
considerably smaller than that of either propylene glycol 
monostearate films or ethoxylated stearyl alcohol films 
(Table IV). The improved film strength and integrity as 
judged by the minimum isolatable film thickness might be 
due to more efficient arrangement, orientation, and packing 
of molecules in the films of mixed composition. Increase 
in the content of ethoxylated stearyl alcohol from 10 to 
20% wjw did not result in corresponding improvement in 
minimum isolatable thicknesses of the films. 
c) Modulus of Elasticity: 
The results of Sward hardness and modulus of elas-
ticity determination are reported in Table V. The variation 
-4 of dry film thickness (maximum variation 1.6 x 10 inches 
or 4.06 x 10-4 em) was minimized to ensure comparable results 
of modulus of elasti~ity. Relatively low values of modulus 
of elasticity obtained for all films might be attributed 
to the slight tackiness of the films. The inclusion of 
ethoxylated stearyl alcohol in the propylene glycol mono-
stearate films did not have substantial effect on the modulus 
---------------~-------~"~"~--~-~~~"-- -------,---~-
_ ....... ,.,_, .. 
Table V. Sward Hardness and Modulus of Elasticity of Selected Plropylene Glycol 
Monostearate-Ethoxylated Stearyl Alcohol Films. 
Mean Dry Film b Constant for a 
Film Thickness (x 103) Given Thickness 




100 0 0.433 0.58 2 
0 100 0.307 0.10 2 
90 10 0.465 0.68 2 
80 20 0.346 0.21 2 
aExpressed as propylene glycol monostearate 




bExpressed as mean of five measurements. 
Modulus of 
Elasticity 2 (E), psi(Kgjcm ) 
5.72 (0.40) 
2.76 (0.19) 
5.41 (0. 38) 
4.06 (0.29) 
alcohol ratio, 




of elasticity perhaps due to associated tackiness. 
Release Kinetics 
The release of cortisol from films containing vary-
ing proportions of propylene glycol monostearate and ethoxy-
lated stearyl alcohol was investigated to study the effect 
of film composition, drug concentration, and agitation. 
-------'JTh-e-s-6--------l!-es-u-l-t-s-h-a-\~e-9e-e-n-f-u.-~t-ll-er-a-n-a-J..-y-z-e-Gl-a-n-Gl-i-n-t-e-!!-FH'!_e-t-e-d.---------
to gain additional insight into the drug release mechanism. 
a) Effect of Film Composition: 
As anticipated, films containing only propylene glycol 
monostearate as the film former did not release significant 
amounts of cortisol in the aqueous medium over a twelve hour 
period due to relative insolubility of the film former in 
water (Table VI). On the other hand, films of ethoxylated 
stearyl alcohol were found to release their entire cortisol 
content within about 30 minutes (Table VII). The film and 
its drug content were found to have dissolved completely 
during this period. 
Films of mixed composition containing varying propor-
tions of the two film formers could be expected to show drug 
release profile somewhere between the two aforementioned 
extremes. The compositions of all films investigated for 
drug release are listed in Table I. Initial trial runs 
were conducted with various films containing 4% wjw cortisol, 
and increasing ethoxylated stearyl alcohol from O% to 10% wjw 
---------------~----'----~"---




Time % Drug Amount Released Q! 0 2 
min. Absorbance Released mg mgjdm
2 mgfcm 
I 
60 0.014 0.86 0.069 0.02r2 0.280 
120 0.015 0.95 0.076 o.or 0.279 
240 0.017 1.15 0.092 o.or 0.279 
360 0.019 1.32 0.105 0.0 i4 0.278 w 
0) 
480 0.020 1.41 0.112 0. 0Ci4 0.278 
0.021 0.278 600 1. 53 0.122 0. 00i4 
720 0.022 1. 62 0.129 0. 0Ci5 0.277 
I 
aQ = 0.282 mgfcm 2 
0 




Time % Drug Amount Released 0 2 
min. Absorbance Released mg mgjam mgfcm 
I 
5 0.143 ll. 56 0.915 : :j: 0.248 10 0.863 71.09 5.628 0.081 
15 1.197 99.39 7.868 0.2r 0.002 
20 1.188 99.62 7.886 0.2r 0.001 "' ""' 25 1.178 99.76 7.897 0.2r 0.001 




= 0.280 mgjcm 2 
3·5 
with a corresponding decrease of propylene glycol mono-
stearate concentration (Tables VIII-XII). A trend towards 
gradual but small increase in the release rate of cortisol 
was evident. The film No. 7 containing 10% wjw ethoxylated 
stearyl alcohol was found to release approximately 15% of 
the drug contained in the film at the end of twelve hours 
(Table XII). Therefore, interest is mainly focused on 
drug release from film compositions containing 10% wjw or 
more ethoxylated stearyl alcohol. 
Several films containing 4% wjw cortisol and start-
ing from 10% wjw of ethoxylated stearyl alcohol with an 
increment of l% wjw and a proportionately decreasing amount 
of propylene glycol monostearate were investigated (Tables 
XIII-XXII). The cumulative cortisol released at each time 
interval over twelve hour period was found to increase as 
the proportion of ethoxylated stearyl alcohol in the film 
increased from 10 to 20% wjw (Figures 4 and 5). The cumula-
tive drug release versus time profiles for films No. 7 
through 17 revealed an interesting curvature effect. For 
films No. 7, 8, 9, and 10, the release rate was found to 
increase with time, resulting in a gradually rising curve. 
The effect was more easily discernible after 5 hours. On the 
other hand, release rate declined with time for films No. 
12-17 as evidenced by the subtle but definite reversal in 
the shape of the curves. This interesting behavior could 
be explained as follows: Following the relatively rapid 
""9 • -- -· 




Time % Drug Amount Released 0 2 
min. Absorbance Release mg mgf[m 
mgfcm 
I 
60 0.012 0.72 0.057 0. 011)2 0.278 
120 0.013 0.87 0.069 0. 011)2 0.278 
240 0.015 1.10 0.087 0. 0113 0.277 
360 0.017 l. 39 0.110 0. 01)4 0.276 "' m 
480 0.018 l. 58 0.125 0. 0114 0.276 
600 0.020 l. 86 0.147 
:::J:: 
0.275 
720 0.021 2.07 0.164 0.274 
I - --··--- ------ -··-··-- ---- ------
- I 
aPGM : ESA : co = 94:2:4 
bQ = 0.280 mgfcm 2 
0 
--------------------------------~---------·~·----~· 
... ·~~ .. ~.~. ~~~ 
Table IX. Release of Cortisol from Film No. 4a· 
Cumulative Q - Qb 
Time % Drug Amount Released 
I Q 2 0 2 min. Absorbance Release mg mgycm mgjcm 
0.93 0.075 
r 
60 0.015 o.fo3 0.283 
120 1.21 0.098 0.017 0.11)03 0.283 
0.140 240 0.022 l. 73 0 .11)05 0.281 
360 0.026 2.18 0.176 0.11)06 0.280 
480 0.030 2.69 0.218 0.11)08 0.278 w 
--J 
600 0.034 3.24 0.262 0.009 0.277 
I 
720 0.038 3.82 0.309 0.011 0.275 
aPGM:ESA:CO = 92:4:4 
bQ = 0.286 mgjcm 2 
0 
"'""' 














= 0.284 mgjcm 
Cumulative 
% Drug Amount Released 
Release mg 
0.93 0.075 
l. 22 0.098 











0 .I 03 0.281 
0 -~~05 0.279 
0 .1)07 0.277 
'-" 0 .1)09 0.275 00. 
o. mu 0.273 
I 
o.m13 0. 271 
Table XI. Release of Cortisol from Film No. 6a 
Cumulative I~ Q -Qb Time % Drug Amount Released 
mgrcm
2 0 2 min. Absorbance Release mg mgfcm 
60 0.018 l. 21 0.096 0.003 0.278 
0.1~06 120 0.026 2.01 0.160 0.275 
0. !~07 240 0.033 2.65 0.210 0.274 
I 
360 0. 043 3.86 0.306 O.IHl 0.270 
I w 
480 0.054 5.09 0.404 O.Oll4 0.267 <D 
6.76 
I 
600 0.069 0.536 0. ~)19 0.262 
I 
720 0.090 9.00 0.714 0. ~)25 0.256 
I 
aPGM:ESA:CO ~ 88:8:4 
bQ ~ 0.281 mgfcm2 
0 
~~--~~====="=···=-...,-,='==~=-
Table XII. Release of Cortisol from Film No. 7a 
I 
Cumulative m~om' Q - Qb Time % Drug Amount Released 0 2 min. Absorbance Release mg mgjcm 
30 0.024 1.67 0.135 0.1005 0.281 
60 0.027 l. 91 0.154 0. 005 0.281 
90 0.030 2.19 0.177 0. 006 0.280 
120 0.033 2.48 0.200 0. 007 0.279 
180 0.042 3.21 0.259 0. 009 0.277 
240 0.055 4.32 0.349 0. 012 0.274 
300 0.066 5.21 0.421 0. 015 0.271 
360 0.081 6.49 0. 524 0. 018 0.267 
420 0.095 7.70 0.622 0. 022 0.264 "" 480 0.109 8.89 0.718 0. 025 0.260 0 
540 0.125 10.27 0.830 0. 029 0.256 
600 0.142 ll. 75 0.949 0. 034 0.252 
660 0.159 13.23 1.069 0. 038 0.248 
720 0.177 14.84 1.199 0. 042 0.243 
aPGM:ESA:CO = 86:10:4 
bQ = 0.286 mgfcm 2 
0 
- ·r.--· 
-·----·--·· ......... ----- .---, 




Time % Drug Amount Released 0 2 
min. Absorbance Release mg mg{cm mgjcm 
I 
30 0.032 2.42 0.186 0. ~)07 0.265 
' 60 0.036 2.80 0.215 O.UJ08 0.264 
' 90 0.038 2.98 0.229 0.008 0.264 
3.55 ' 120 0.044 0.273 0. (,10 0.262 
180 0.054 4.41 0.339 o.q12 0.260 
240 0.063 5.23 0.402 0. 0114 0.258 
300 0.077 6.49 0.499 o.q18 0.254 
360 0.090 7.65 0.588 0.021 0.251 
420 0.104 8.89 0.684 0. ~124 0.248 .,. 
480 0.119 10.27 0.790 0. ql28 0.244 >-" 
540 0.135 11.74 0.903 0.(/32 0.240 
600 0.151 13.22 l. 017 o.q36 0.236 
660 0.165 14.56 1.120 0.040 0.232 
720 0.182 16.15 1.242 o. ci44 0.228 
---· .. ~-· ------- -~-
aPGM:ESA:CO ~ 85:11:4 
bQ ~ 0.272 mgjcm2 
0 
-------------~----~~-~~~ .. ~~~=~~~=~~-~-------
Table XIV. Release of Cortisol from Film No. 9a 
I 
Cumulative I Q - Qb 
Time % Drug Amount Released ~ 0 2 2 min. Absorbance Release mg mg1cm mgjcm 
0.306 
-1 
0.262 30 0.050 3.97 0.~11 60 0.056 4.51 0.348 0. 112 0.260 
90 0.060 4.86 0.375 0. 113 0.259 
120 0.069 5.69 0.439 0. 116 0.257 
180 0.086 7.19 0.554 0.~20 0. 253 
240 0.105 8.88 0.685 0. 124 0.249 
300 0.127 10.84 0.836 o.d3o 0.243 
360 0.149 12.81 0.988 o.g35 0.238 ""' 420 0.170 14.70 1.133 0.~40 0.233 "' 
480 0.193 16.82 1.297 0. 46 0.227 
540 0.214 18.73 1.444 0.~51 0.222 
600 0.238 20.97 1.617 0. ,57 0.216 
660 9.258 22.84 l. 761 o. o162 0.211 720 0.281 25.05 1.931 0.0168 0.205 
I 
aPGM:ESA:CO = 84:12:4 
bQ = 0.273 mgjcm2 
0 
------------------------------~------~~~~--~ ==- -·-"""' 
Table XV. Release of Cortisol from Film No. lOa 
1, 
Cumulative J Q -Qb Time % Drug Amount Released 0 2 2 min. Absorbance Release mg mg~cm mgjcm 
30 0.058 5.12 0.417 o.d115 0.273 60 0.064 5.65 0.460 0.0116 0.272 
90 0.070 6.19 0.504 0. 0118 0.270 
120 0.077 6.81 0.554 0.0120 0.268 
180 0.097 10.07 0.820 0.0129 0.259 
240 0.127 13.19 l. 074 0.0138 0.250 
300 0.168 17.01 1.385 o.r9 0.239 
.. 
360 0.211 19.79 1.611 0.057 0.231 
(;) 
420 0.261 22.22 1.809 0.049 0.239 
480 0.309 25.70 2.092 0.0 74 0.214 
540 0.373 28.48 2.318 0.0 82 0.206 
600 0.442 31.61 2.573 0.0 91 0.197 
660 0.509 34.39 2.799 0.0 99 0.189 
720 0.575 39.59 3.223 0.1 14 0.174 
I 
aPGM:ESA:CO ~ 83:13:4 




Table XVI. Release of Cortisol from Film No. lla 
1. 
Cumulative I Q -Qb 
Time % Drug Amount Released (Q 0 
mgrcm
2 2 min. Absorbance Release mg mgjcm 
I 
30 0.069 5.55 0.429 0. ~)15 0.259 
60 0.088 7.23 0.559 0. ~/20 0.254 
90 0.106 8.82 0.682 0. ~)24 0.250 
120 0.129 10.85 0.839 0. ~/30 0.244 
180 0.176 14.95 1.156 O.Ul4l 0.233 
240 0.223 19.06 1.473 o . (,>52 0.222 
' 300 0.270 23.23 1.796 g: ~:~; 0.210 360 0.315 27.26 2.107 0.199 
420 0.361 31.40 2.427 0.086 0.188 
"" 480 0.402 35.19 2.720 O.Cl96 0.178 "'" 540 0.442 38.90 3.007 0. :1 06 0.168 
600 0.485 42.92 3.318 O.Jl7 0.157 
660 0.518 46.13 3.566 0. J26 0.148 
720 0.556 49.75 3. 846 0.:1136 0.138 
-- -- --- ----- --- -r 
aPGM:ESA:CO = 82:14:4 
bQ
0 
= 0.274 mgjcm 2 
""DO -• -··-' 
Table XVII. Release of Cortisol from Film No. 12a 
I. 
Cumulative I Q - Qb 
Time % Drug Amount Released CQ 
I 2 0 2 
min. Absorbance Release mg mg1cm mgjcm 
-1 
30 0.097 7.57 0.612 0.022 0.264 
60 0.144 . 11.47 0.927 0. 0133 0.253 
90 0.187 15.07 l. 218 0.043 0.243 
120 0.224 18.29 1.478 o.d52 0.234 
180 0.293 23.97 1.937 0. dl69 0.217 
240 0.362 29.78 2.406 o.d85 0.201 
300 0.421 34.85 2.816 o. :loo 0.186 
360 0.480 39.98 3.230 0. Jl4 0.172 
420 0.535 44.81 3.621 0. J28 0.158 
.,. 
49.03 3.962 0. J40 
Cn 
480 0.582 0.146 
540 0.630 53.40 4.315 0. J53 0.133 
600 0.676 57.62 4.656 0. Ji65 0.121 
660 0.716 61.44 4.964 o.JI76 0.110 
720 0.759 65.47 5.290 o.JI87 0.099 
II 
aPGM:ESA:CO ~ 81:15:4 
bQ
0 
~ 0.286 mgjcm 2 
--------------"------~~~"-- --- ~ ~~~-~~-----~--·--
Table XVIII. Release of Cortisol from Film No. 13a 
I 
·cumulative I Q - Qb 





min. Absorbance Release mg mgfcm 
I 
I 
30 0.082 6.15 0.509 o.~n8 0.275 
60 0.098 7. 52 0.622 o. 022 0.271 
' 90 0.144 ll. 28 0.933 0. ~)33 0.260 
120 0.186 14.70 1.216 O.M3 0.250 
' 180 0.280 22.22 l. 838 0.065 0. 228 
' 240 0.354 28.37 2.346 0.083 0.210 
300 0.415 33.49 2.770 0.~98 0.195 
360 0.498 40.34 3.336 0.118 0.175 
420 0.545 44.44 3.675 o.bo 0.163 
480 0.604 49.56 4.099 O.lL45 0.148 ,. 
' 
(l) 
540 0.663 54.69 4.523 0.163 0.133 
600 0.717 59.48 4.919 o.h4 0.119 
' 660 0. 757 63.24 5.230 O.l,~85 0.108 
720 0.801 67.34 5.569 0.197 0.096 
--·· -- ------- ------ ---------- I 
I 
aPGM:ESA:CO = 80:16:4 
bQ = 0.293 mgfcm 2 
0 
r ,,,J·-····,.-· ----------------
Table XIX. Release of Cortisol from Film No. l4a 
I 
Cumulative 
I Q - Qb 
Time % Drug Amount Released Q 2 0 2 
min. Absorbance Release mg mgl(cm mgfcm 
.I 
I 
30 0.089 6.69 0.561 0.020 0.277 
60 0.139 10.66 0.894 0.1?32 0.265 
90 0.189 14.66 1.230 o.p44 0. 253 
120 0.244 19.09 l. 602 0.057 0.240 
27.62 2.317 ' 0.215 180 0.351 0. ~)82 
240 0.458 36.26 3.042 O.l08 0.189 
' 30D 0.542 43.16 3.62l 0.128 0.169 
50.26 ' 360 0.628 4.217 0. :,L49 0.148 
420 0.715 57.54 4.828 0.171 0.126 
480 63.11 5.295 ' 0.779 0.187 0.110 "'" ' 540 0.840 68.47 5.745 0.?03 0.094 .;)
600 0.896 73.49 6.166 o.p8 0.079 
660 0.947 78.18 6.559 0. :;~32 0.065 
720 0.977 81.20 6.813 0. ~~41 0.056 
---- ---- ---
I 
aPGM:ESA:CO = 79:17:4 
bQ
0 
= 0.297 mgfcm 2 
"""' -~~ 
































aPGM:ESA:CO = 78:18:4 







































































































aPGM:ESA:CO = 77:19:4 
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Q - Qb 
Time % Drug Amount Released IQ 2 0 2 min. Absorbance Release mg mgl(cm mgjcm 
I 
30 0.122 9.89 0.777 0.1527 0.251 
60 0.199 16.40 1.289 0.1 46 0.232 
90 0.271 22.56 1.773 0.1?63 0.215 
120 0.352 29.50 2.319 o.p82 0.196 
180 0.469 39.57 3.110 0. !llO 0.168 
240 0.585 49.61 3.899 o.b8 0.140 
300 0.676 57.65 4.531 0. :il60 0.118 
360 0.768 65.88 5.178 0.1183 0.095 
"' I " 420 0.844 72.85 5.726 0.'203 0.075 6 I 
480 0.906 78.70 6.186 
L~H 
0.059 
540 0.958 83.77 6.584 0.045 
600 0.999 87.99 6.916 0.033 
660 1..018 90.38 7.104 o./.251 0.027 
720 l. 031 92.33 7.257 0~257 0.021 
aPGM:ESA:CO = 76:20:4 
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dissolution from the film surface, continuing dissolution of 
ethoxylated stearyl alcohol from deep within the film matrix 
increased the porosity of the film, thereby increasing the 
surface area available for contact between the drug in the 
film and the dissolution medium, thus accounting for a gradu-
ally increasing release rate with time for each of the films 
No. 7,8,9, and 10. The rate of drug release throug~h~o~u~t~t~h~e ____________ _ 
observed release period was low enough that drug concentra-
tion in the film did not become a rate-limiting factor. The 
ethoxylated stearyl alcohol content and rate of drug release 
from films No. 7,8,9, and 10 were such that drug concentration 
at the film interface with dissolution medium was not appre-
ciably altered. However, as the proportion of ethoxylated 
stearyl alcohol in the films increased further, such as films 
No. 12-17, the resulting high rate of drug release served to 
deplete the drug from the films rather rapidly. This was 
evidenced by the gradual leveling tendency of the curves due 
to declining rates of drug release from each of these films. 
A close examination of Figure 4 revealed that drug release 
profile for film No. 11 containing 14% wjw ethoxylated stearyl 
alcohol was nearly linear for 10 hours with a slight tendency 
to level off during the last two hours of drug release period. 
This suggested that various factors such as declining ethoxy-
lated stearyl alcohol content of the films, increasing sur-
face area of contact between drug and the dissolution medium, 
and the declining concentration of the drug at the film inter-
face were in a state of dynamic equilibrium for the 10 hour 
54 
duration of the release period providing a constant rate of 
drug release from film No. 11. The rising curvature of the 
drug release versus time profiles for films No. 7,8,9, and 
10 might be due to predominating influence of increases in 
surface area of contact between drug molecules and dissolu-
tion medium while declining curvatures of films No. 12-17 
were more likely due to predominating influence of drug 
depletion in the films. 
The release data obtained in this study were ex-
amined by both Higuchi's model and first-order mechanism. 
Observed data were analyzed and interpreted to test the 
fitness of either model. The correlation coefficients for 
the best statistical lines and lag times (time intercept 
extrapolated to Q=O) were used as the major criteria for 
evaluation. 
The first order rate plots (Figures 6 and 7) con-
firmed our earlier analysis based upon plots of cumulative 
amount of drug released versus time. All firms included 
in the study demonstrated good first-order release profile 
for first five hours of drug release (correlation coefficients, 
0:990-0.999). Divergence from the first-order relationship 
was noted as the ethoxylated stearyl alcohol: propylene 
glycol monostearate ratio increased. The drug release from 
films No. 7 and 8 appeared to follow first-order profile for 
the entire twelve hour period of study. Divergence from 
linearity was first noted after the 11-hour data point for 
films No. 9 and 10, and after 10 hour data point for films 
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No. 11 and 12. The duration for which the slope remained 
constant decreased as the ethoxylated stearyl alcohol : 
propylene glycol monostearate ratio in the film increased. 
The films No. 16 and 17 followed first-order profile for 
the minimum duration of about 4-5 hours. These observa-
tions have served to confirm that dynamics of release pro-
cess changed as the ethoxylated stearyl alcohol : propylene 
glycol monostearate ratio was altered. For most cases, the 
lag times were no more than several minutes (Table XXIII). 
The negative lag times might be attributed to the immediate 
release of the drug present on the film surface. Varying 
amounts of cortisol present on the film surface might ac-
count for the magnitude of the lag times. The first-order 
release rate constants (Table XXIII) increased about 13-fold 
(0.21 to 2.8 per minute) as the ethoxylated stearyl alcohol 
content of the film was increased from 10 to 20% wjw (ethoxy-
lated stearyl alcohol:propylene glycol monostearate ratio 
changed from 1.16 to 2.63). This increase was approximately 
linear for films No. 7-17 (Figure 8). 
Cortisol release data for films No. 7 through 17 
were also analyzed to test compliance with Higuchi's model 
which predicts a linear relationship between amount of drug 
released per unit area (Q) and square root of time (t) 
~ 
Q ; Kt 2 (Eq. 3) 
Table XXIII. First-order Treatment of Data for the ReLease ofl Cortisol. 
Film Film % Drug Release Release Rate Llag Time Correlation 
No. Compositiona After 12 Hours Constant (kx1000) 
I min Coefficient min-1 
7 86:10:4 14.84 0.211 14.84 0.990 
8 85:11:4 16.15 0.218 -4~.58 0.991 
9 84:12:4 25.05 0. 356 -4~.01 0.995 
10 83:13:4 39.59 0.635 -,5. 08 0.992 
11 82:14:4 49.75 0.906 -1,6.84 0.998 
12 81:15:4 65.47 1. 392 -1:,8. 10 0.999 
13 80:16:4 67.34 1.410 )1.00 0.999 
79:17:4 l. 912 ' 14 81.20 '2.84 0.999 en 
15 78:18:4 84.61 l. 951 
I 
-11,5.37 0.999 co 
16 77:19:4 91.93 2.709 -11.76 0.999 
17 76:20:4 92.33. I 2.803 -r.oo o.999 
aProportion of propylene glycol monostearate, ethoxylated stealryl alcohol and 
cortisol expressed as % wjw. 
~ 
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60 
for either homogeneous or granular film matrix. Since solu-
bility of cortisol could be assumed to be negligible in the 
film compositions investigated, Equation 2 describing the 
drug release from a granular matrix might be more applicable. 
Q = rlD'- (2A-EC )C t 
T s s (Eq. 2) 
Since solubility of cortisol in water is 0.28 mgjml at 25° 
(26), even at maximum release, drug concentration in the 
dissolution medium never exceeded beyond 10% of the reported 
drug solubility, thus ensuring near perfect sink conditions. 
It could not be readily ascertained whether total amount of 
drug present in the matrix per unit volume (A) was at least 
3-4 times greater than the product of porosity (E) and solu-
bility of the drug in the permeating fluid (Cs) as required 
by Higuchi's model for granular matrix. However, based upon 
the observation that films of mixed composition had more com-
pact packing of molecules, it might be assumed that porosity 
of the films was extremely low at least initially, thus en-
suring A>>EC in the early stages of the study. Careful 
s 
1 
examination of Q versus t~ plots (Figures 9 and 10) revealed 
a distinct curvilinear effect for all film compositions 
rather than predicted straight lines. The deviation from the 
Higuchi model could possibly be due to rapid dissolution of 
ethoxylated stearyl alcohol even though it did not constitute 
more than 20% of the film matrix. Higuchi's model does not 
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Effect of Drug Concentration 
Film No. 11 (PGM:ESA:CO = 82:14:4) and No. 12 (PGM: 
ESA:CO = 81:15:4) were selected for evaluating the effects 
of changes in drug concentration on release behavior. The 
drug concentration was varied from 1 to 4% wjw with corres-
ponding adjustment of propylene glycol monostearate and 
ethoxylated stearyl alcohol content such that PGM:ESA ratio 
1~--------r~eamm~a~ined constant at a value or-~86 for variations of film 
11 and at 5.4 for corresponding variations of film 12. The 
release data are presented in Figure 11 and Tables XXIV-XXVII 
for congeners of film 11 (film 18, 19, and 20), and in Figure 
12 and Tables XXVIII-XXXI for varients of film 12 (film 
21, 22, and 23). 
The rate controlling effects of changes in drug con-
centration over the duration of release period were most 
apparent when drug content of the film was lowered to 1% 
wjw. This could be seen as the changing curvature of the 
drug release profile in Figures 11 and 12 for films 20 and 
23, respectively. First-order plots (Figures 13 and 14) 
further confirmed this finding. The data in Tables XXVII 
and XXXI revealed that first-order rate constant remained 
nearly constant between the drug concentration range of 3 
to 4% wjw but the rate constant increased as the drug con-
centration dropped below 3% wjw. The sharp increase in re-
lease rate constant (k) when drug concentration was lowered 
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Figure 11. Cumulative Drug Release versus Time: Effect of qhange 
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Table XXIV. Release of Cortisol from Film No. 18a 
Cumulative Q - Qb 
Time % Drug Amount Released Q 2 0 2 
min. Absorbance Release mg mgfcm mgfcm 
30 0.039 3.88 0.234 0.008 0.205 
60 0.054 5.56 0.335 0.012 0.201 
90 0.074 7.75 0.467 0.017 0.196 
120 0.098 10.42 0.628 0.022 0.191 
180 0.143 15.45 0.931 0.033 0.180 
240 0.183 19.94 1.201 0.042 0.171 
300 0.224 24.57 1.480 0.052 0.161 
360 0.261 28.78 l. 734 0.061 0.152 ()) 
420 0.299 33.25 2.003 0.071 0.142 
()1 
480 0. 334 37.35 2.250 0.080 0.133 
540 0.370 41.65 2.509 0.089 0.124 
600 0.404 45.73 2.755 0.097 0.116 
660 0.439 49.95 3.009 0.106 0.107 
720 0.472 54.00 3.253 0.115 0.098 
a PGM:ESA:CO = 82.85:14.15:3 
bQ
0 
= 0.213 mgfcm2 
Table XXV. Release of Cortisol from Film No. l9a 
Cumulative 
Q - Qb Time % Drug Amount Released Q 2 
min. Absorbance Release mg mgfcm m'gfcm2 
30 0.019 2.56 0.102 0.004 0.137 
60 0.032 4. 76 0.190 0.007 0.134 
90 0.050 7.74 0.309 O.Oll 0.130 
120 0.078 12.40 0.495 0.018 0.123 
180 0.126 20.34 0.812 0.029 O.ll2 
240 0.163 26.63 1.063 0.038 0.103 
300 0.205 33.79 1.349 0.048 0.093 
360 0. 234 38.85 1.551 0.055 0.086 Ol 
420 0.270 45.17 1.803 0.064 0.077 Ol 
480 0.298 50.18 2.003 0.071 0.070 
540 0.330 55.84 2.229 0. 079 0.062 
600 0.351 59.82 2.388 0.084 0.057 
660 0.375 64.30 2.567 0.091 0.050 
720 0. 397 68.51 2.735 0.097 0.044 
a PGM:ESA:CO = 83.71:14.29:2 
bQ = 0.141 mgfcm 2 
0 
Table XXVI. Release of Cortisol from Film No. 20a 
Cumulative 
b Time % Drug Amount Released Q 2 Qo - ~ 
min. Absorbance Release mg mgjcm mgjcm 
30 0.018 4.77 0.096 0.003 0.068 
60 0.029 8.39 0.169 0.006 0.065 
90 0.047 14.30 0.288 0.010 0.061 
120 0.070 21.90 0.441 0.016 0.055 
180 0.115 36.69 0.739 0.026 0.045 
240 0.160 51.79 1.043 0.037 0.034 
300 0.196 63.90 1.287 0.046 0.025 m 
360 0.225 73.93 1.489 0.053 0.018 ""' 420 0.248 82.22 1.656 0.059 0.012 
480 0.261 87.19 1.756 0.062 0.009 
540 0.268 90.27 1.818 0.064 0.007 
600 0.271 92.16 1.856 0.066 0.005 
660 0.275 94.24 1.898 0.067 0.004 
720 0.279 96.47 1.943 0.069 0.002 
-
a PGM:ESA:CO = 84.56:14.44:1 
bQ
0 
= 0.071 mgfcm 2 
·~·"~-=-- --·-··-
Table XXVII. Effect of Drug Concentration 
First-Order Treatment of Data for the Release ~)f Cortisol 
I 
Drug kxl0 3 Correlation 
PGM:ESA Ratio Concentration min-1 Coefficient 
wjw% wjw% r 
84.56 14.44 1 2.334 0.983 
83.71 .: 14.29 2 1.473 0.997 
82.85 14.15 3 0.905 0.999 
()) 
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Table XXVIII. Release of Cortisol from Film No. 21a 
Cumulative 
Q -Qb Time % Drug Amount Released Q 
min. Absorbance Release mg mgfcm2 m<g;cm2 
30 0.069 7.15 0.429 0.015 0.197 
60 0.099 10.51 0.631 0.022 0.190 
90 0.130 13.97 0.838 0.030 0.182 
120 0.162 17.60 1.056 0.037 0.175 
180 0.179 24.62 1.477 0.052 0.160 
240 0.278 30.65 1.839 0.065 0.147 
300 0.326 36.25 2.175 0.077 0.135 
360 0.366 40.90 2.454 0.087 0.125 ""' 420 0.408 45.85 2.751 0.097 0.115 0 
480 0.461 52.03 3.122 0.110 0.102 
540 0.499 56.68 3.401 0.120 0.092 
600 0.539 61.62 3.697 0.131 0.081 
660 0.572 66.25 3.975 0.141 0.071 
720 0.618 71.42 4.285 0.152 0.060 
a PGM:ESA:CO = 81.84:15.16:3 
bQ = 0.211 mgfcm 2 
0 
r 
Table XXIX. Release of Cortisol from Film No. 22a 
Cumulative b Time % Drug Amount Released Q 2 Qo-Q 
min. Absorbance Release mg mgfcm mgfcm2 
30 0.043 6.35 0.258 0.009 0.135 
60 0.063 9.68 0. 393 0.014 0.130 
90 0.088 13.84 0.562 0.020 0.124 
120 0.127 20.18 0.820 0.029 0.115 
180 0.173 27.86 1.131 0.040 0.104 
240 0.215 34.85 1.415 0.050 0.094 ~ 
300 0.256 41.77 1.696 0.060 0.084 1-' 
360 0.300 49.43 2.007 0.071 0.073 
420 0.332 55.00 2.233 0. 079 0.065 
480 0.359 59.90 2.432 0.086 0.058 
540 0.386 64.75 2.629 0.093 0.051 
600 0.410 69.19 2.809 0.099 0.045 
660 0.440 74.68 3.032 0.107 0.037 
720 0.460 78.72 3.196 0.113 0.031 
I 
a PGM:ESA:CO = 82.69:15.31:2 
bQ = 0.144 mgfcm 2 
0 
----------------------------~------~'------------~~------~--~ 
Table XXX. Release of Cortisol from Film No. 23a 
Cumulative 
~ ~b Time % Drug Amount Released Q 
min. Absorbance Release mg mgfcm2 mgfcm 
30 0.202 5.18 0.108 0.004 0.070 
60 0.031 8.82 0.184 0.007 0.067 
90 0.050 14.68 0.306 O.Oll 0.063 
120 0.074 22.45 0.468 0.017 0.057 
180 O.ll9 36.79 0. 767 0.027 0.047 
240 0.168 52.71 1.099 0.039 0.035 
-.:) 
tv 
300 0.204 64.36 l. 341 0.047 0.027 
360 0.233 74.29 1.549 0.055 0.019 
420 0.260 83.35 1.739 0.061 0.013 
480 0.274 88.63 1.848 0.065 0.009 
540 0.283 92.23 1.923 0.068 0.006 
600 0.288 94.67 1.974 0.070 0.004 
660 0.292 96.74 2.017 0.071 0.003 
720 0.295 98.51 2.054 0.073 0.001 
a PGM:ESA:CO = 83.53:15.47:1 
bQ = 0.074 
0 
Table XXXI. Effect of Drug Concentration 
First-Order Treatment of Data for the Release oj' Cortisol 
Drug kx10 3 Correlation 
PGM:ESA Ratio Concentration min-1 Coefficient 
wfw% wfw% r 
83.53 : 15.47 1 2.260 0.983 
82.69 15.31 2 1. 785 0.998 
-'1 
81.84 15.16 3 1.413 0.999 
w 
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76 
release mechanism. What is the effect of increasing drug 
content in films beyond 4% wjw? What is the relationship 
between drug concentration of films and PGM:ESA ratio, 
particularly for films with 10% wjw or less ethoxylated 
stearyl alcohol? Additional studies are warranted to answer 
these questions and explain the drug release mechanism. 
Effect of Agitation Rate 
The film composition of 81% wjw propylene glycol 
monostearate, 15% wjw ethoxylated stearyl alcohol, and 4% 
wjw cortisol was selected (Film No. 12, Table I), and the 
release studies were conducted at the agitation speeds 
of 10, 30, 50, and 80 revolutions per minute. This experi-
ment was carried out in the same dissolution apparatus des-
cribed earlier (Figure 1). The cortisol release from the 
film was found to follow first-order profile at four rates 
of agitation investigated (Table XXXII, XXXIII, XXXIV, 
XXXV). The plot of release rate constants versus agitation 
speeds is shown in Figure 15. The release rate constant 
increased about two-fold as agitation speed increased from 
10 to 80 rpm. 
An empirical equation suggested by Wurster and Taylor 
(27) described the relationship between rate constant and 
agitation speed for dissolution of drugs. 
K = a (N)b (Eq. 8) 
Table XXXII. Release of Cortisol from Film No. 12 at Agitation J3peed of· 10 rpm 
Cumulative Q -Qa 
Time % Drug Amount Released Q 2 0 2 
min. Absorbance Release mg mgjcm 
mgjcm 
30 0.094 7.43 0.594 0. dl21 0.262 
60 0.137 11.00 0.879 0.031 0.252 
90 0.178 14.49 1.158 o. dl41 0.242 
' 120 0.214 17.56 1.403 o. q5o 0.233 
180 0.277 22.92 1.831 0. 0165 0.218 
240 0.335 27.87 2.227 o.q19 0.204 
300 0.391 32.77 2.618 0.093 0.190 
360 0.447 37.66 3.009 0. J06 0.177 -.:] 
I 
-.:] 
420 0.484 40.83 3.262 0.115 0.168 
480 0.520 43.99 3.515 0. :J 24 0.159 
540 0.563 47.95 3.831 0. :J 36 0.147 
600 0.609 52.17 4.168 0. J47 0.136 
660 0.645 q5.63 4.445 0. J.57 0.126 
720 0.681 59.09 4.721 O.J67 0.116 
I ----
I 
a 2 Q = 0.283 mgfcm 
0 
--~--~~--~~~·---------------------





Q - Qa 
Time % Drug Amount Released 0 2 min. Absorbance Release mg mgjcm 
L 
30 0.087 6.95 0. 546 0.1>19 0.259 
60 0.151 12.35 0.971 0.1,)34 0.244 
90 0.189 15.65 1.230 0.1544 0.234 
120 0.226 18.89 1.485 0.11 53 0.225 
180 0.295 24.81 1.950 0. ~)69 0.209 
240 0.362 30.62 2.407 0.1,)85 0.193 
300 0.431 36.68 2.883 0.102 0.176 
42.26 3.322 
I 
360 0.494 0.118 0.160. 
420 47.94 3.768 
I -.:] 0.557 0.133 0.145 
I 00 
480 0.604 52.29 4.ll0 0.145 0.133 
540 0.659 57.37 4.509 
I o.:1L59 0.119 
600 0.701 61.42 4.828 0.171 0.107 
660 0. 743 65.48 5.147 ' 0.182 0.096 





= 0.278 mgfcm 2 

















































































































First-order Treatment of Data for the Effect o~ Agitation on 
Cortisol Release from Film No. 12 
Release Rate Correlation 
% Drug Release · Consta~t-fkxlOOO) Lag.~ime Coefficient 
After 12 Hours m1n mln r 
59.09 1.146 -43. 56 0.999 
65.47 1.392 -18. 10 0.999 
69.26 l. 571 -6. 70 0.998 
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where, K = reaction rate, 
a = constant, 
N = agitation or stirring rate, and 
b =constant. 
The value of b was predicted to be 1 or near 1 if 
the reaction was diffusion controlled. The reactions con-
affected by the agitation intensity and b should approach 
zero. If both processes were influential in the control 
of the rate, b should vary between zero and 1 if a suf-
· ficiently wide range of agitation intensities were employed. 
The value of b calculated from the data using the following 
relationship (Equation 9) derived from Equation 8 was 
= (Eq. 9) 
found to be 0.393 suggesting that drug release was not simple 
diffusion-controlled process and possibly other interfacial 
factors were involved. This analysis is in agreement with 
conclusions derived elsewhere in this study based upon a 
thorough analysis of drug release profiles from films of 
varying compositions. 
Clinical Potential 
Zero-order drug release from long-acting controlled 
drug delivery systems is a highly desirable attribute. This 
investigation has shown that by appropriate manipulation 
of ethoxylated stearyl alcohol : propylene glycol monostearate 
83 
ratio and the drug concentration in the film, a long-acting 
topical drug delivery system for cortisol with constant 
(pseudo-zero-order) release profile can be potentially de-
veloped. The film No. 11 containing 82% wjw propylene glycol 
monostearate, 14% wjw ethoxylated stearyl alcohol, and 4% 
wjw cortisol has been shown to have a constant drug release 
1~------~F~--for ro-hours, and may have a promising cl1n1cal~~e~n"-------------­
tial. Conceivably, this film could also serve as a vehicle 
for controlled release of other drugs as well. 
SUMMARY AND CONCLUSION 
In this study, several experiments were conducted 
for the initial screening of the characteristics of propylene 
glycol monostearate and ethoxylated stearyl alcohol films. 
The data obtained from the preliminary evaluation 
suggested that the suitable combination of the two film 
formers might provide a means of controlling the rate and 
extent of release of cortisol over a prolonged period. 
The results of this study have demonstrated controlled 
release of cortisol from several compositions of films con-
taining varying proportions of propylene glycol monostearate 
and ethoxylated stearyl alcohol. An important finding of 
this study is that film No. 11 containing 82% wfw propylene 
glycol monostearate, 14% wfw ethoxylated stearyl alcohol, 
and 4% wfw cortisol provides constant release rate for nearly 
10 hours. 
The release data were analyzed and interpreted to 
test if mechanism of drug release followed Higuchi's model 
or some other mechanism. The release of cortisol from propy-
lene glycol monostearate-ethoxylated stearyl alcohol films 
was found to be a complex process rather than a simple dif-
fusion or leaching of drug from the films. The potential 
clinical application of the film No. 11 with constant re-
lease rate profile for cortisol deserves further study. 
84 
85 
Propylene glycol monostearate-ethoxylated stearyl alcohol 
films may offer promising potential for delivery of other 
drugs as well. Although this investigation has emphasized 
topical application of the films, such compositions and the 
underlying concepts deserve further study with respect to 
other routes of drug delivery. 
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